Form 4: Bio-Rad Laboratories Executive Receives Stock Grant
Insider Transaction (Form 4)
Courtney C Enloe, EVP, General Counsel & Sec of Bio-Rad Laboratories, Inc., reported multiple transactions in common stock on September 4, 2026.
Summary
- Option exercise/conversion: acquired 685 Bio-Rad A Common Stock on September 5, 2026; holds 1,435 after (Direct).
- Tax/exercise-price withholding: disposed of 246 Bio-Rad A Common Stock at $386.11 ($94,983) on September 5, 2026; holds 1,189 after (Direct).
- Option exercise/conversion: acquired 768 Bio-Rad A Common Stock on September 6, 2026; holds 1,957 after (Direct).
- Tax/exercise-price withholding: disposed of 305 Bio-Rad A Common Stock at $386.11 ($117,764) on September 6, 2026; holds 1,652 after (Direct).
- Grant/award: acquired 2,876 Restricted Stock Units on September 4, 2026; holds 2,876 after (Direct).
- Option exercise/conversion: disposed of 685 Restricted Stock Units on September 5, 2026; holds 2,055 after (Direct).
- Option exercise/conversion: disposed of 768 Restricted Stock Units on September 6, 2026; holds 1,536 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Courtney C Enloe — Officer (EVP, General Counsel & Sec)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-05 | Option exercise/conversion | Bio-Rad A Common Stock | 685 | — | — | 1,434.777 |
| 2026-09-05 | Tax/exercise-price withholding | Bio-Rad A Common Stock | 246 | $386 | $95.0K | 1,188.777 |
| 2026-09-06 | Option exercise/conversion | Bio-Rad A Common Stock | 768 | — | — | 1,956.777 |
| 2026-09-06 | Tax/exercise-price withholding | Bio-Rad A Common Stock | 305 | $386 | $117.8K | 1,651.777 |
| 2026-09-04 | Grant/award | Restricted Stock Units | 2,876 | — | — | 2,876 |
| 2026-09-05 | Option exercise/conversion | Restricted Stock Units | 685 | — | — | 2,055 |
| 2026-09-06 | Option exercise/conversion | Restricted Stock Units | 768 | — | — | 1,536 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-05 | Option exercise/conversion (685 shares) |
| 2026-09-05 | Tax/exercise-price withholding (246 shares) |
| 2026-09-06 | Option exercise/conversion (768 shares) |
| 2026-09-06 | Tax/exercise-price withholding (305 shares) |
| 2026-09-04 | Grant/award (2,876 shares) |
| 2026-09-05 | Option exercise/conversion (685 shares) |
| 2026-09-06 | Option exercise/conversion (768 shares) |
Keywords
insider transaction, Form 4, BIO BIO.B, BIO-RAD LABORATORIES, INC., neutral, Courtney C Enloe
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.